The Trader: The importance of high beta stocks
Michael looks at two examples of high-beta stocks offering news to trade. For anyone wanting to trade intraday then high beta stocks – stocks that
Michael Taylor
29th September 2023
ARTICLES
& INSIGHT
All the latest articles & insight from our investment writers to inspire your own research and analysis.
Author Index
-
Alpesh Patel OBEAlpesh Patel OBE
-
Bruce PackardBruce Packard
-
David StevensonDavid Stevenson
-
Jamie WardJamie Ward
-
Jason NeedhamJason Needham
Author Index
-
Maynard PatonMaynard Paton
-
Michael TaylorMichael Taylor
-
Phil OakleyPhil Oakley
-
Richard BeddardRichard Beddard
-
Robbie BurnsRobbie Burns
Monthly Funds focus: Biopharma & Hipgnosis
There’s something of an income theme to this month’s funds focus. First up is a specialist lending fund whose shares have fallen sharply in value
David Stevenson
29th September 2023
Is SDI cheap?
Shares in SDI have plummeted. Richard examines the price differential between the company, a manufacturer of scientific equipment, and Judges Scientific, a firm it is
Richard Beddard
27th September 2023
Weekly Market Commentary | 26/09/23 | HL., CODE, 4BB | Not just the UK housing market
Bruce suggests that government bonds and mortgages have been beneficiaries of Basel banking regulations over the last few decades. The effects of rising interest rates
Bruce Packard
26th September 2023
Small-Cap Spotlight Report: NCC (LSE: NCC)
Many great companies still can’t resist ‘diworsifiying’ in the quest for growth. Maynard Paton studies IT specialist NCC and its costly folly beyond software escrow.
Maynard Paton
22nd September 2023
Private Investing: Why the free tools on your broker’s website aren’t good enough
If you already have an Isa or Sipp account, you’ll have access to your broker’s free website. This probably provides you with investment data about
Phil Oakley
21st September 2023
Is it a good time to buy housebuilder shares?
House building in the UK has experienced numerous peaks and troughs with shareholders in listed housebuilders experiencing similar fortunes. Buying housebuilder shares when they are
Phil Oakley
20th September 2023
Weekly Market Commentary | 19/09/23 | ELIX, FEVR, FDEV | Investing against the flows
Bruce suggests that rather than ARM’s successful IPO, the likely catalyst for more companies coming to market will be retail flows into funds. Companies covered
Bruce Packard
19th September 2023
Private Investing: What is investing?
Why do people invest their money rather than just save? It’s not just about growing your savings so that you will have more money
Phil Oakley
15th September 2023
The Trader: Does Arm’s success mean the IPO market is back?
The market saw a boom in new listings in 2020 and 2021 as companies were greedy to slurp on the capital market teat that provided
Michael Taylor
15th September 2023
Four companies with (almost) unblemished financial histories
Richard picks holes in the financial histories of four companies and finds little to trouble him. Remarkably Cake Box, a company that published an annual
Richard Beddard
13th September 2023
Weekly Market Commentary | 12/09/23 | BUR, STVG, WINK, CVSG | Chaos Kings
Bruce reviews a recent book Chaos Kings, on investors who benefit from financial crises and volatility. Companies covered BUR, STVG, WINK and CVSG. The FTSE
Bruce Packard
12th September 2023